Target intelligence / Profile preview

RNA polymerase III subunit K pseudogene 2 (POLR3KP2)

Target
POLR3KP2
Molecular classification
Other, Pseudogene
01

Overview

POLR3KP2 refers to an RNA polymerase III subunit K pseudogene 2. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional due to mutations, deletions, or truncations that prevent proper transcription or translation. POLR3KP2 is not listed among the 17 functional subunits of human RNA polymerase III, nor is it described in structural, genetic, or disease literature regarding Pol III composition or related disorders[4][5]. As a pseudogene, it is not considered a therapeutic target and is not involved in RNA transcription or any known cellular functions. RNA polymerase III (Pol III) is a multi-subunit enzyme that transcribes small noncoding RNAs (tRNAs, 5S rRNA, U6 snRNA, etc.), with subunits such as POLR3A (RPC1), POLR3B (RPC2), POLR3K (subunit K/RPC10) being part of the active enzyme[2][4][5]. However, pseudogene variants like POLR3KP2 do not encode these functional proteins and are generally excluded from canonical protein lists and structural analyses. No evidence from current scientific literature suggests POLR3KP2 plays any direct biological role or is relevant for disease, therapy, drug targeting, or biomarker development[2][4][5]. If your query seeks functional RNA polymerase III subunits, refer to genes like POLR3A, POLR3B, and POLR3K rather than pseudogenes such as POLR3KP2.

Other names
POLR3KP2

Beyond the preview

Go deeper on RNA polymerase III subunit K pseudogene 2 (POLR3KP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA polymerase III subunit K pseudogene 2 (POLR3KP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call